22808010|t|Defining an EPOR- regulated transcriptome for primary progenitors, including Tnfr-sf13c as a novel mediator of EPO- dependent erythroblast formation.
22808010|a|Certain concepts concerning EPO/EPOR action modes have been challenged by in vivo studies: Bcl-x levels are elevated in maturing erythroblasts, but not in their progenitors; truncated EPOR alleles that lack a major p85/PI3K recruitment site nonetheless promote polycythemia; and Erk1 disruption unexpectedly bolsters erythropoiesis. To discover novel EPO/EPOR action routes, global transcriptome analyses presently are applied to interrogate EPO/EPOR effects on primary bone marrow-derived CFUe-like progenitors. Overall, 160 EPO/EPOR target transcripts were significantly modulated 2-to 21.8-fold. A unique set of EPO-regulated survival factors included Lyl1, Gas5, Pim3, Pim1, Bim, Trib3 and Serpina 3g. EPO/EPOR-modulated cell cycle mediators included Cdc25a, Btg3, Cyclin-d2, p27-kip1, Cyclin-g2 and CyclinB1-IP-1. EPO regulation of signal transduction factors was also interestingly complex. For example, not only Socs3 plus Socs2 but also Spred2, Spred1 and Eaf1 were EPO-induced as negative-feedback components. Socs2, plus five additional targets, further proved to comprise new EPOR/Jak2/Stat5 response genes (which are important for erythropoiesis during anemia). Among receptors, an atypical TNF-receptor Tnfr-sf13c was up-modulated    >5-fold by EPO. Functionally, Tnfr-sf13c ligation proved to both promote proerythroblast survival, and substantially enhance erythroblast formation. The EPOR therefore engages a sophisticated set of transcriptome response circuits, with Tnfr-sf13c deployed as one novel positive regulator of proerythroblast formation.
22808010	12	16	EPOR	GeneOrGeneProduct	13857
22808010	77	87	Tnfr-sf13c	GeneOrGeneProduct	72049
22808010	111	114	EPO	GeneOrGeneProduct	13856
22808010	178	181	EPO	GeneOrGeneProduct	13856
22808010	182	186	EPOR	GeneOrGeneProduct	13857
22808010	241	246	Bcl-x	GeneOrGeneProduct	12048
22808010	334	338	EPOR	GeneOrGeneProduct	13857
22808010	365	373	p85/PI3K	GeneOrGeneProduct	18708
22808010	411	423	polycythemia	DiseaseOrPhenotypicFeature	D011086
22808010	429	433	Erk1	GeneOrGeneProduct	26417
22808010	501	504	EPO	GeneOrGeneProduct	13856
22808010	505	509	EPOR	GeneOrGeneProduct	13857
22808010	592	595	EPO	GeneOrGeneProduct	13856
22808010	596	600	EPOR	GeneOrGeneProduct	13857
22808010	676	679	EPO	GeneOrGeneProduct	13856
22808010	680	684	EPOR	GeneOrGeneProduct	13857
22808010	765	768	EPO	GeneOrGeneProduct	13856
22808010	805	809	Lyl1	GeneOrGeneProduct	17095
22808010	811	815	Gas5	GeneOrGeneProduct	14455
22808010	817	821	Pim3	GeneOrGeneProduct	223775
22808010	823	827	Pim1	GeneOrGeneProduct	18712
22808010	829	832	Bim	GeneOrGeneProduct	12125
22808010	834	839	Trib3	GeneOrGeneProduct	228775
22808010	844	854	Serpina 3g	GeneOrGeneProduct	20715
22808010	856	859	EPO	GeneOrGeneProduct	13856
22808010	860	864	EPOR	GeneOrGeneProduct	13857
22808010	905	911	Cdc25a	GeneOrGeneProduct	12530
22808010	913	917	Btg3	GeneOrGeneProduct	12228
22808010	919	928	Cyclin-d2	GeneOrGeneProduct	12444
22808010	930	938	p27-kip1	GeneOrGeneProduct	12576
22808010	940	949	Cyclin-g2	GeneOrGeneProduct	12452
22808010	954	967	CyclinB1-IP-1	GeneOrGeneProduct	239083
22808010	969	972	EPO	GeneOrGeneProduct	13856
22808010	1069	1074	Socs3	GeneOrGeneProduct	12702
22808010	1080	1085	Socs2	GeneOrGeneProduct	216233
22808010	1095	1101	Spred2	GeneOrGeneProduct	114716
22808010	1103	1109	Spred1	GeneOrGeneProduct	114715
22808010	1114	1118	Eaf1	GeneOrGeneProduct	74427
22808010	1124	1127	EPO	GeneOrGeneProduct	13856
22808010	1169	1174	Socs2	GeneOrGeneProduct	216233
22808010	1237	1241	EPOR	GeneOrGeneProduct	13857
22808010	1242	1246	Jak2	GeneOrGeneProduct	16452
22808010	1247	1252	Stat5	GeneOrGeneProduct	20850
22808010	1315	1321	anemia	DiseaseOrPhenotypicFeature	D000740
22808010	1353	1365	TNF-receptor	GeneOrGeneProduct	72049
22808010	1366	1376	Tnfr-sf13c	GeneOrGeneProduct	72049
22808010	1408	1411	EPO	GeneOrGeneProduct	13856
22808010	1427	1437	Tnfr-sf13c	GeneOrGeneProduct	72049
22808010	1550	1554	EPOR	GeneOrGeneProduct	13857
22808010	1634	1644	Tnfr-sf13c	GeneOrGeneProduct	72049
22808010	Association	20850	D000740	Novel
22808010	Association	16452	D000740	Novel
22808010	Positive_Correlation	74427	13856	Novel
22808010	Positive_Correlation	114715	13856	Novel
22808010	Positive_Correlation	114716	13856	Novel
22808010	Association	216233	D000740	Novel
22808010	Positive_Correlation	216233	13856	No
22808010	Positive_Correlation	12702	13856	No
22808010	Association	13856	17095	Novel
22808010	Association	13856	239083	Novel
22808010	Association	13856	12452	No
22808010	Association	13856	12576	No
22808010	Association	13856	12444	No
22808010	Association	13856	12228	Novel
22808010	Association	13856	12530	Novel
22808010	Association	13856	20715	No
22808010	Association	13856	228775	No
22808010	Association	13856	12125	No
22808010	Association	13856	18712	No
22808010	Association	13856	223775	No
22808010	Association	13856	14455	Novel
22808010	Bind	13856	13857	No
22808010	Positive_Correlation	72049	13856	Novel
22808010	Association	13857	18708	No
22808010	Association	13857	D011086	No
22808010	Association	13857	D000740	Novel
22808010	Association	13857	239083	Novel
22808010	Association	13857	12452	No
22808010	Association	13857	12576	No
22808010	Association	13857	12444	No
22808010	Association	13857	12228	Novel
22808010	Association	13857	12530	Novel
22808010	Association	13857	72049	Novel